Who we are

Across all four sites, our leading neurologists have a neuroimmunological focus and are embedded in strong neuroscientific and immunological communities.  In addition, each site makes its own specific contributions to the initiative.  Leading the research at each of these sites are:

  • Rhine-Main Neuroscience Network: Stefan Bittner, Tobias Bopp, Sergiu Groppa, Helmut Jonuleit, Jonathan Kipnis, Detlef Schuppan,  Albrecht Stroh, Jacky Trotter, Ari Waisman, Nina Wettschureck and Frauke Zipp
  • Munich neuroimmunologists: Klaus Dornmair, Bernhard Hemmer, Reinhard Hohlfeld, Naoto Kawakami, Martin Kerschensteiner, Thomas Korn , Gurumoorthy Krishnamoorthy, Klaus Lehmann-Horn, Edgar Meinl and Mikael Simons
  • Münster Center: Thomas Budde, Catharina Groß, Luisa Klotz, Tanja Kuhlmann, Karin Loser, Sven Meuth, Hans-Christian Pape, Michael Schäfers, Nicholas Schwab, Lydia Sorokin, Heinz Wiendl and Alexander Zarbock
  • Bochum Center: Ralf Gold and Aiden Haghikia

News

Tue, 17/10/2017
Three new CRC associates
Muenster / Mainz / Munich. The CRC is proud to welcome three scientists as new associates: Muthuraman Muthuraman (Mainz), Anneli Peters (LMU) and Gerd Meyer zu Hörste (Münster). All three are reputable neuroimmunologists, who add their in-depth knowledge of techniques and concepts to the existing team. Dr. Muthuraman Muthuraman is head of the scientific working group […]...more
Tue, 12/09/2017
Genetically altered mice provide initial evidence that human gut bacteria can trigger multiple sclerosis
Munich. (LMU)  Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. There are many indications that MS is an autoimmune disease in which immune cells “accidentally” attack the brain and spinal cord. However, as with other autoimmune diseases, the actual triggers of the autoimmune reaction are still unknown. A new […]...more
Sun, 10/09/2017
SFB researcher acquired Hertie foundation funding
Munich. SFB CRC 128 researcher Dr. Klaus Lehmann-Horn, Department of Neurology, has acquired 396.000€ of funding as part of the framework „MyLab“, which is sponsored by the Hertie foundation. The duration of the project „Antigen-driven affinity maturation of B lymphocytes in meningeal ectopic lymphoid tissue in a model of Multiple Sclerosis“ will be 5 years, […]...more